North America Molecular Diagnostics Market Analysis And Segment Forecasts To 2024
Phone No.: +1 (214) 884-6817 sales@orbisresearch.com
Email id:
North America Molecular Diagnostics Market Analysis And Segment Forecasts To 2024 The North America molecular diagnostics market is expected to reach over USD 7.2 billion by 2024, according to a new report by Grand View Research, Inc. As a developed economy, North America has a well-equipped healthcare infrastructure. Moreover, the U.S. healthcare expenditure is projected to increase at a substantial rate over the forecast period. Technological advancement in molecular diagnostic kits is expected to serve the as a primary driving force. Extensive R&D activities undertaken by the major companies for expansion of their product portfolio is another factor supporting growth. For instance, in 2015, a strategic collaboration was made between Sysmex Corporation and Laboratory Corporation in the field of blood-based molecular diagnostic tests to develop precision medicine in oncology. Browse the report: http://www.orbisresearch.com/reports/index/north-america-moleculardiagnostics-market-analysis-by-product-test-location-technology-application-and-segmentforecasts-to-2024 Reagents dominated the molecular diagnostics market with revenue of over USD 1.0 billion in 2015, owing to increasing R&D initiatives and as a result of discovery of novel biomarkers for cancer. Moreover, the fastest growing segment over the forecast period is also expected to be reagents, due to increasing adoption in the process of drug discovery.
Phone No.: +1 (214) 884-6817
Email id: sales@orbisresearch.com
North America Molecular Diagnostics Market Analysis And Segment Forecasts To 2024 Some key players in the market include Abbott Laboratories; Roche Diagnostics; Hologic, Inc. (Gen Probe); Novartis AG; Bio-Rad laboratories, Inc.; Cepheid; Siemens Healthineers GmbH; Johnson & Johnson Services, Inc.; Bayer AG; Alere; bioMĂŠrieux SA; Sysmex Corporation; Becton, Dickinson and Company (BD); Danaher Corporation; Dako; and QIAGEN. Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/129587 The strategies implemented by the participants include innovations through introduction of devices providing quick test results of blood samples and expansion to emerging markets.
Phone No.: +1 (214) 884-6817
Email id: sales@orbisresearch.com
North America Molecular Diagnostics Market Analysis And Segment Forecasts To 2024 About Us: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors accross the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information: 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A. Phone No.: +1 (214) 884-6817 enquiry@orbisresearch.com sales@orbisresearch.com Phone No.: +1 (214) 884-6817
Email id: sales@orbisresearch.com